Eurocine Vaccines has been invited to present at BOS R&D Outsourcing Week together with Biovian Oy, Turku, Finland.

In the presentation, Eurocine Vaccines will describe the selection process, through which Biovian was selected as the CDMO for the vaccine candidate against Chlamydia trachomatis. The key criteria in the selection of a CDMO will be reviewed.

The two companies will share how a successful relationship between a biotech and a CDMO is prepared, agreed and conducted. The event, which is entirely virtual and scheduled 28 June to 2 July 2021, will cover R&D Outsourcing and connect stakeholders all across the biotech industry.